Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BOLD Boundless Bio, Inc.

盘后交易 03-26 16:00:05 EDT

1.10

-0.03

-2.48%

最高1.14	最低1.10	成交量5.10万
今开1.13	昨收1.13	日振幅3.54%
总市值2,467万	流通市值1,814万	总股本2,239万
成交额5.74万	换手率0.31%	流通股本1,646万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BOLD","market":"US","secType":"STK","nameCN":"Boundless Bio, Inc.","latestPrice":1.102,"timestamp":1774555192013,"preClose":1.13,"halted":0,"volume":50996,"delay":0,"changeRate":-0.02477876106194673,"floatShares":16462050,"shares":22385611,"eps":-2.602728,"marketStatus":"盘后交易","change":-0.028,"latestTime":"03-26 16:00:05 EDT","open":1.13,"high":1.14,"low":1.1,"amount":57357.455223200006,"amplitude":0.035398,"askPrice":1.22,"askSize":111,"bidPrice":1.1,"bidSize":10810,"shortable":3,"etf":0,"ttmEps":-2.602728,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1711598400000,"exchange":"NASDAQ","adjPreClose":1.13,"volumeRatio":0.826663},"requestUrl":"/m/hq/s/BOLD","defaultTab":"news","newsList":[{"id":"2609754617","title":"Boundless Bio, Inc.盘中异动 急速上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609754617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609754617?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:32","pubTimestamp":1770388349,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时32分，Boundless Bio, Inc.股票出现异动，股价快速上涨5.50%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Liminatus Pharma Inc C/Wts 30/04/2030 、Roivant Sciences Ltd.涨幅较大，Clearmind Medicine Inc.、Aim Immunotech Inc.、Liminatus Pharma, Inc.较为活跃，换手率分别为406.64%、11.93%、10.05%，振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Transcode Therapeutics, Inc.、Vyome Holdings, Inc.，振幅分别为18.03%、10.63%、9.57%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223230a6dc09fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223230a6dc09fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"1163208228","title":"Boundless Bio Inc：优化产品组合策略，包括终止Potentiate试验，将运营资金延长至2028年下半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1163208228","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163208228?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:09","pubTimestamp":1768910972,"startTime":"0","endTime":"0","summary":"Boundless Bio Inc宣布通过产品组合优先排序计划，显著延长了公司的运营资金期限。这一战略调整包含终止其名为Potentiate的临床试验项目。经过此番优化，公司预计现有资金将足以支持运营至2028年下半年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"1167402543","title":"Boundless Bio公司：BBI-940新药临床试验申请获批，首个人体试验计划于2026年上半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1167402543","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167402543?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:09","pubTimestamp":1768910954,"startTime":"0","endTime":"0","summary":"Boundless Bio公司宣布，其研发的BBI-940新药临床试验申请已正式获得监管机构批准。这一重要进展为公司在2026年上半年启动首个人体临床试验奠定了坚实基础，标志着该创新疗法向临床转化迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2588050287","title":"Boundless Bio, Inc.盘中异动 早盘大幅下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588050287?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:30","pubTimestamp":1764603051,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日23时30分，Boundless Bio, Inc.股票出现异动，股价快速下挫5.13%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。其相关个股中，Q32 Bio Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Q32 Bio Inc.、Kala Bio, Inc.、Aditxt, Inc.较为活跃，换手率分别为1007.10%、828.06%、72.92%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Q32 Bio Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为101.36%、100.45%、64.00%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012330519524eeb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012330519524eeb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2583074775","title":"Boundless Bio, Inc.2025财年第三财季实现净利润-13.88百万美元，同比增加15.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583074775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583074775?lang=zh_cn&edition=full","pubTime":"2025-11-14 00:00","pubTimestamp":1763049659,"startTime":"0","endTime":"0","summary":"11月14日，Boundless Bio, Inc.公布财报，公告显示公司2025财年第三财季净利润为-13.88百万美元，同比增加15.93%；其中营业收入为0.00美元，每股基本收益为-0.62美元。从资产负债表来看，Boundless Bio, Inc.总负债58.55百万美元，其中短期债务3.05百万美元，资产负债比为0.03，流动比率为0.11。机构评级：截至2025年11月14日，当前有2家机构对Boundless Bio, Inc.目标价做出预测，其中目标均价为3.50美元，其中最低目标价为3.00美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000226950290a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000226950290a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD"],"gpt_icon":0},{"id":"2581777251","title":"Boundless Bio, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581777251?lang=zh_cn&edition=full","pubTime":"2025-11-05 03:01","pubTimestamp":1762282910,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时01分，Boundless Bio, Inc.股票出现波动，股价急速下挫5.11%。截至发稿，该股报1.30美元/股，成交量4.6255万股，换手率0.21%，振幅4.01%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Terns Pharmaceuticals, Inc.、Metsera, Inc.、Relmada Therapeutics, Inc.涨幅较大，Artelo Biosciences, Inc.、Abpro Holdings, Inc、Biomx Inc.较为活跃，换手率分别为305.04%、117.76%、73.95%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为52.50%、47.93%、40.90%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105030150a6e11cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105030150a6e11cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2518077462","title":"Boundless Bio, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518077462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518077462?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:57","pubTimestamp":1741636620,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时57分，Boundless Bio, Inc.股票出现波动，股价大幅下挫5.33%。截至发稿，该股报1.60美元/股，成交量21.9333万股，换手率0.98%，振幅6.51%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6553.54%、3901.81%、1040.86%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035700a26ab9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035700a26ab9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2517864167","title":"Boundless Bio, Inc.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517864167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517864167?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:09","pubTimestamp":1741277363,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时09分，Boundless Bio, Inc.股票出现异动，股价大幅拉升5.00%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2901.55%、1902.03%、127.01%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为68.33%、67.37%、57.40%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000923a262a7fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000923a262a7fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2517926003","title":"Boundless Bio, Inc.盘中异动 下午盘股价大涨5.78%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517926003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517926003?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:27","pubTimestamp":1741206442,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时27分，Boundless Bio, Inc.股票出现波动，股价急速拉升5.78%。截至发稿，该股报1.83美元/股，成交量17.9883万股，换手率0.81%，振幅5.20%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为974.03%、318.47%、317.09%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为82.59%、54.27%、51.93%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042723abea143b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042723abea143b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2516652889","title":"Boundless Bio, Inc.盘中异动 急速下跌5.18%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652889?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:11","pubTimestamp":1741025496,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时11分，Boundless Bio, Inc.股票出现异动，股价快速下挫5.18%。截至发稿，该股报1.83美元/股，成交量3.1296万股，换手率0.14%，振幅3.24%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4350.56%、185.58%、179.09%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021136989a420f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021136989a420f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2516749573","title":"Boundless Bio, Inc.盘中异动 临近午盘急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516749573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516749573?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:50","pubTimestamp":1740761412,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时50分，Boundless Bio, Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报2.00美元/股，成交量1.5722万股，换手率0.07%，振幅3.16%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3011.58%、494.01%、369.17%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为57.80%、48.19%、46.60%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010050129634399b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010050129634399b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2514852171","title":"Boundless Bio, Inc.盘中异动 早盘股价大涨6.79%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514852171?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:49","pubTimestamp":1740584943,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时49分，Boundless Bio, Inc.股票出现波动，股价大幅拉升6.79%。截至发稿，该股报1.97美元/股，成交量1.3459万股，换手率0.06%，振幅7.88%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5369.10%、204.11%、188.65%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为161.02%、43.31%、39.47%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226234903a255092d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226234903a255092d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2513213338","title":"Boundless Bio, Inc.盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513213338?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:13","pubTimestamp":1740158014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时13分，Boundless Bio, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报2.10美元/股，成交量11.417万股，换手率0.51%，振幅1.50%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为238.67%、216.50%、128.06%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为72.46%、57.50%、48.35%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222011334988e01cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222011334988e01cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2513929737","title":"Liquity将于3月中旬重新部署V2，建议现有V2用户平仓和关闭贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2513929737","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513929737?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:25","pubTimestamp":1740155119,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/LiquityProtocol/status/1892943503489179877","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2512199223","title":"Boundless Bio, Inc.盘中异动 下午盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512199223?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:57","pubTimestamp":1739908671,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时57分，Boundless Bio, Inc.股票出现异动，股价大幅下跌5.13%。截至发稿，该股报2.13美元/股，成交量4.8742万股，换手率0.22%，振幅5.36%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为882.07%、212.96%、171.13%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219035752abd3f1eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219035752abd3f1eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2511767691","title":"Boundless Bio, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511767691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511767691?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:18","pubTimestamp":1739546294,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时18分，Boundless Bio, Inc.股票出现波动，股价大幅上涨5.36%。截至发稿，该股报2.36美元/股，成交量2765股，换手率0.01%，振幅2.01%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2369.11%、618.37%、471.63%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231814988594d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231814988594d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2511298265","title":"Boundless Bio, Inc.盘中异动 早盘快速上涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511298265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511298265?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:54","pubTimestamp":1739458493,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时54分，Boundless Bio, Inc.股票出现波动，股价快速上涨6.36%。截至发稿，该股报2.34美元/股，成交量629股，换手率0.00%，振幅1.36%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1495.08%、1091.86%、117.21%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为92.30%、73.65%、32.86%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213225453abcdb6c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213225453abcdb6c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2509789867","title":"Boundless Bio, Inc.盘中异动 下午盘股价大跌5.08%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509789867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509789867?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:22","pubTimestamp":1738956171,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时22分，Boundless Bio, Inc.股票出现波动，股价大幅下挫5.08%。截至发稿，该股报2.24美元/股，成交量1.6881万股，换手率0.08%，振幅6.14%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Nutriband Inc C/Wts 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为8395.29%、180.72%、142.13%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、56.78%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032251961b6943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032251961b6943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2509097822","title":"Boundless Bio, Inc.盘中异动 快速下挫5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509097822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509097822?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:03","pubTimestamp":1738861407,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时03分，Boundless Bio, Inc.股票出现异动，股价急速下挫5.60%。截至发稿，该股报2.36美元/股，成交量1.3216万股，换手率0.06%，振幅3.80%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为6048.35%、1576.02%、160.61%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、53.00%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207010327abc4f39f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207010327abc4f39f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2509723574","title":"Boundless Bio, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509723574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509723574?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:17","pubTimestamp":1738772255,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时17分，Boundless Bio, Inc.股票出现波动，股价大幅上涨5.02%。截至发稿，该股报2.30美元/股，成交量2073股，换手率0.01%，振幅2.28%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4257.61%、1776.72%、1305.42%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为99.51%、59.80%、54.05%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600173596191b8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600173596191b8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boundlessbio.com","stockEarnings":[{"period":"1week","weight":-0.0342},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0088},{"period":"1year","weight":-0.2938},{"period":"ytd","weight":-0.0583}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Boundless Bio, Inc.最初成立于2018年4月10日，原名Pretzel Therapeutics, Inc.，是一家特拉华州公司。2019年7月8日，公司更名为Boundless Bio, Inc.。他们是一家临床阶段的肿瘤学公司，致力于开启癌症治疗的新方式，通过靶向染色体外DNA（ecDNA）来解决癌基因扩增肿瘤患者的显著未满足需求，在超过14%的癌症患者中观察到癌基因扩增的根本原因。他们的使命是成为领先的生物制药公司，利用ecDNA生物学提供变革性的治疗方法，改善和延长患有先前难治性癌基因扩增癌的患者的生命。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.045467},{"month":2,"riseRate":0.25,"avgChangeRate":0.036219},{"month":3,"riseRate":0.666667,"avgChangeRate":0.088311},{"month":4,"riseRate":0.333333,"avgChangeRate":0.028717},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.032827},{"month":6,"riseRate":1,"avgChangeRate":0.142257},{"month":7,"riseRate":0.666667,"avgChangeRate":0.021175},{"month":8,"riseRate":0.5,"avgChangeRate":-0.031707},{"month":9,"riseRate":0.75,"avgChangeRate":0.116011},{"month":10,"riseRate":0,"avgChangeRate":-0.120737},{"month":11,"riseRate":0.75,"avgChangeRate":0.014772},{"month":12,"riseRate":0.75,"avgChangeRate":0.282026}],"exchange":"NASDAQ","name":"Boundless Bio, Inc.","nameEN":"Boundless Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Boundless Bio, Inc.,BOLD,Boundless Bio, Inc.股票,Boundless Bio, Inc.股票老虎,Boundless Bio, Inc.股票老虎国际,Boundless Bio, Inc.行情,Boundless Bio, Inc.股票行情,Boundless Bio, Inc.股价,Boundless Bio, Inc.股市,Boundless Bio, Inc.股票价格,Boundless Bio, Inc.股票交易,Boundless Bio, Inc.股票购买,Boundless Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况